Loading
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Oct 2024 for CERO THERAPEUTICS HOLDINGS, INC.. Read the official filing
Filing timeline
BuySaleChristopher B. Ehrlich
Insider track record
Disclosed buys
6
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-58.8%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Christopher B. Ehrlich: trading record in brief
Filings by Christopher B. Ehrlich span 2 companies, the busiest being eFFECTOR Therapeutics, Inc. and Cero Therapeutics Holdings, Inc. Over a trading history stretching from 25 August 2021 to 25 September 2024, the count stands at 10 filings.
Purchases make up the whole of the open-market record (6 purchases, €198). The amount is not disclosed for 5 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 option exercise.
The record was last updated on 2 October 2024 with an option exercise in Cero Therapeutics Holdings, Inc. The most recent open-market purchase was published on 6 October 2022, 1,473 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Christopher B. Ehrlich
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
5,312,983 sharesCommon StockSEC:0001213900-24-084830:0
1,125,000 sharesCommon StockSEC:0001213900-24-015026:0
346 shares@ US$0.570.2% of flowCommon StockSEC:0001209191-22-052933:0
Canonical exit: 2 Jan 2023 (T+90)
18,867 shares@ €0.571515.5% of flowCommon StockSEC:0001209191-22-051313:0
Canonical exit: 25 Dec 2022 (T+90)
2,000 shares@ €3.915511.3% of flowCommon StockSEC:0001209191-22-011731:0
Canonical exit: 15 May 2022 (T+90)
1,000 shares@ €4.29966.2% of flowCommon StockSEC:0001209191-22-008529:0
Canonical exit: 9 May 2022 (T+90)
5,000 shares@ €4.557532.8% of flowCommon StockSEC:0001209191-22-007349:0
Canonical exit: 4 May 2022 (T+90)
5,000 shares@ €4.716533.9% of flowCommon StockSEC:0001209191-22-005721:0
Canonical exit: 27 Apr 2022 (T+90)
36,733 shares@ US$10.00100.0% of flowClass A common stockSEC:0000899243-21-039941:0
142,168 shares0Common StockSEC:0001209191-21-053731:0
10 of 10 declarations
